Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/157905| Author(s): | Gonçalves, J Santos, CD Fresco, P Fernandez-Llimos, F |
| Title: | Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one |
| Issue Date: | 2024 |
| Abstract: | [No abstract available] |
| DOI: | 10.1016/j.repc.2023.10.005 |
| URI: | https://hdl.handle.net/10216/157905 |
| Document Type: | Outra Publicação em Revista Científica Internacional |
| Rights: | openAccess |
| Appears in Collections: | FFUP - Outra Publicação em Revista Científica Internacional |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 666087.pdf | 271.09 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.